These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8316945)
1. Isolation and characterization of two new functional subtypes of HLA-B35. Theiler G; Pando M; Delfino JM; Takiguchi M; Satz ML Tissue Antigens; 1993 Mar; 41(3):143-7. PubMed ID: 8316945 [TBL] [Abstract][Full Text] [Related]
2. Allelic heterogeneity of HLA-B35 subtypes in different populations as assessed by DNA typing. Satz ML; Fernández-Viña M; Theiler GC; Marcos YC; Lindel N; Capucchio M; Gorodezky C; Fainboim L; Stastny P Tissue Antigens; 1995 Sep; 46(3 ( Pt 1)):196-203. PubMed ID: 8525479 [TBL] [Abstract][Full Text] [Related]
3. Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA-B35 subtype molecules. Beck Y; Satz L; Takamiya Y; Nakayama S; Ling L; Ishikawa Y; Nagao T; Uchida H; Tokunaga K; Müller C J Exp Med; 1995 Jun; 181(6):2037-48. PubMed ID: 7759996 [TBL] [Abstract][Full Text] [Related]
4. Novel HLA-B35 subtypes: putative gene conversion events with donor sequences from alleles common in native Americans (HLA-B*4002 or B*4801). Marcos CY; Fernández-Vina MA; Lázaro AM; Nulf CJ; Raimondi EH; Stastny P Hum Immunol; 1997 Apr; 53(2):148-55. PubMed ID: 9129972 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction. Khanna R; Silins SL; Weng Z; Gatchell D; Burrows SR; Cooper L Eur J Immunol; 1999 May; 29(5):1587-97. PubMed ID: 10359113 [TBL] [Abstract][Full Text] [Related]
6. The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. Zemmour J; Little AM; Schendel DJ; Parham P J Immunol; 1992 Mar; 148(6):1941-8. PubMed ID: 1541831 [TBL] [Abstract][Full Text] [Related]
7. A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytes. Morel S; Ooms A; Van Pel A; Wölfel T; Brichard VG; van der Bruggen P; Van den Eynde BJ; Degiovanni G Int J Cancer; 1999 Dec; 83(6):755-9. PubMed ID: 10597191 [TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of HLA-B35 alleles and their relationship to HLA-B15 alleles. Cereb N; Kim C; Hughes AL; Yang SY Tissue Antigens; 1997 Apr; 49(4):389-96. PubMed ID: 9151391 [TBL] [Abstract][Full Text] [Related]
9. Two new HLA class I alleles described in a Spanish individual, HLA-A*11:01:01:04 and HLA-B*35:330. Pacho A; Arrieta A; Balas A; De Juan MD; Vicario JL HLA; 2017 Apr; 89(4):236-237. PubMed ID: 28233472 [TBL] [Abstract][Full Text] [Related]
10. Discovery of HLA-B*35:307, a novel HLA-B*35 variant, in a Taiwanese hematopoietic stem cell donor. Yang KL; Hung JH; Lin PY HLA; 2016 Mar; 87(3):178-9. PubMed ID: 26924125 [TBL] [Abstract][Full Text] [Related]
11. A small test of a sequence-based typing method: definition of the B*1520 allele. Domena JD; Little AM; Arnett KL; Adams EJ; Marsh SG; Parham P Tissue Antigens; 1994 Oct; 44(4):217-24. PubMed ID: 7871522 [TBL] [Abstract][Full Text] [Related]
12. Complete nucleotide sequence of a genomic clone encoding HLA-B35 isolated from a Caucasian individual of Hispanic origin. Identification of a new variant of HLA-B35. Chertkoff LP; Herrera M; Fainboim L; Satz ML Hum Immunol; 1991 Jul; 31(3):153-8. PubMed ID: 1890016 [TBL] [Abstract][Full Text] [Related]
13. The relative distribution of B35 alleles and their IEF isotypes in a HLA-B35-positive population. Ragupathi G; Cereb N; Yang SY Tissue Antigens; 1995 Jul; 46(1):24-31. PubMed ID: 7482493 [TBL] [Abstract][Full Text] [Related]
14. Description of a novel HLA-B35 (B*3514) allele found in a Mexican family of Nahua Aztec descent. Vargas-Alarcon G; Martinez-Laso J; Granados J; Diaz-Campos N; Alvarez M; Gomez-Casado E; Alcocer-Varela J; Arnaiz-Villena A Hum Immunol; 1996 Feb; 45(2):148-51. PubMed ID: 8882414 [TBL] [Abstract][Full Text] [Related]
15. Two novel alleles at HLA-B locus identified in two volunteer bone marrow donors by sequence-based typing. Frison S; Longhi E; Mantovani M; Malagoli A; De Giuli A; Piccolo G; Poli F Int J Immunogenet; 2013 Aug; 40(4):328-30. PubMed ID: 23121897 [TBL] [Abstract][Full Text] [Related]
16. Complete sequence of a new HLA-B35 allele found in a tribe of Mapuche Indians in the south of Argentina. Theiler GC; Marcos YC; Kolkowski E; Lindel N; Capucchio M; Barrionuevo P; Carnese FR; Satz ML Immunogenetics; 1996; 43(6):398-9. PubMed ID: 8606062 [No Abstract] [Full Text] [Related]
17. Accumulation of specific amino acid substitutions in HLA-B35-restricted human immunodeficiency virus type 1 cytotoxic T lymphocyte epitopes. Kawana A; Tomiyama H; Takiguchi M; Shioda T; Nakamura T; Iwamoto A AIDS Res Hum Retroviruses; 1999 Aug; 15(12):1099-107. PubMed ID: 10461830 [TBL] [Abstract][Full Text] [Related]
18. Novel HLA-A and HLA-B alleles in South American Indians. Marcos CY; Fernández-Viña MA; Lázaro AM; Moraes ME; Moraes JR; Stastny P Tissue Antigens; 1999 May; 53(5):476-85. PubMed ID: 10372543 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population. Lee SP; Morgan S; Skinner J; Thomas WA; Jones SR; Sutton J; Khanna R; Whittle HC; Rickinson AB Eur J Immunol; 1995 Jan; 25(1):102-10. PubMed ID: 7531142 [TBL] [Abstract][Full Text] [Related]
20. Microheterogeneity in HLA-B35 alleles influences peptide-dependent allorecognition by cytotoxic T cells but not binding of a peptide-restricted monoclonal antibody. Steinle A; Reinhardt C; Nössner E; Uchanska-Ziegler B; Ziegler A; Schendel DJ Hum Immunol; 1993 Dec; 38(4):261-9. PubMed ID: 8138421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]